IP Verse

Aera A/s opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Aera A/s

Patent Number:
EP3574907
Title:
An Nk-1/Nk-3 Receptor Antagonist For The Treatment Of Sex-Hormone-Dependent Diseases
Applicant:
KANDY THERAPEUTICS LIMITED
Opposition Date:
May 23, 2024
Patent Number:
EP2913327
Title:
Methylene Blue And Its Medical Use
Applicant:
PROVENCE TECHNOLOGIES
Opposition Date:
Mar 7, 2024
Patent Number:
EP3678649
Title:
Intranasal Epinephrine Formulations And Methods For The Treatment Of Disease
Applicant:
AEGIS THERAPEUTICS, LLC
Opposition Date:
Jul 24, 2023
Patent Number:
EP2981255
Title:
Therapeutic Uses Of Empagliflozin
Applicant:
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Opposition Date:
Jun 13, 2023
Patent Number:
EP2985026
Title:
Pharmaceutical Delivery Systems For Hydrophobic Drugs And Compositions Comprising Same
Applicant:
CLARUS THERAPEUTICS, INC.
Opposition Date:
Apr 26, 2023
Patent Number:
EP3265115
Title:
Uses Of Pthrp Analogue In Reducing Fracture Risk
Applicant:
RADIUS HEALTH, INC.
Opposition Date:
Mar 21, 2023
Patent Number:
EP3601785
Title:
Coating
Applicant:
APPLIED POLYMER DEVELOPMENTS LIMITED
Opposition Date:
Jul 26, 2022
Patent Number:
EP3391890
Title:
Posaconazole Intravenous Solution Formulations Stabilized By Substituted Beta-Cyclodextrin
Applicant:
MERCK SHARP & DOHME CORP.
Opposition Date:
May 25, 2022
Patent Number:
EP2817000
Title:
Oral Pharmaceutical Compositions Of Dabigatran Etexilate
Applicant:
ESTEVE PHARMACEUTICALS, S.A.
Opposition Date:
May 3, 2022
Patent Number:
EP3053580
Title:
Method Of Providing Pirfenidone Therapy To A Patient
Applicant:
INTERMUNE, INC.
Opposition Date:
Mar 28, 2022

Competitors of Aera A/s

INTERMUNE, INC.

ACTELION PHARMACEUTICALS LTD

AEGIS THERAPEUTICS, LLC

Want to track Aera A/s?

Feel free to send us a message here and we will get back to you